Learn How to Make the EMR Work For You

OSUWexnerbloglogo2014 Learn How to Make the EMR Work For You. A 2015 study in the Mayo Clinic Proceedings found that physicians who use electronic medical records were more likely to get burned out than physicians who did not use EMRs. But there is good news! You can make your electronic medical record work for you rather than the other way around and today we are going to show you how. Joining our moderator in the studio, in this on-line enduring material, is the chief clinical information officer for the OSU Wexner Medical Center, Professor of Family Medicine, Dr. Milisa Rizer, and joining her is our medical center’s deputy chief information officer, Thomas Bentley.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: IDENTIFY the top three factors that improve user efficiency and satisfaction; IDENTIFY the top tools that can be used to improve the amount of time spent in documentation activities; IDENTIFY the two areas of greatest frustration of users of EMRs; IDENTIFY one area where your staff can be used to help with provider efficiency; IDENTIFY one place where you can be involved with improving the EMR in your hospital or clinic.

You’ll also learn about the following:

  • The penetration of electronic medical records into U.S. healthcare
  • Using progress notes as documentation tools versus communication tools
  • Tips to creating reader-friendly referral letters in the electronic medical record
  • Characteristics of successful adopters of electronic medical records
  • Maintaining your “EMR edge”

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

On-line Enduring Material Teaches on Adrenal Nodules

OSUWexnerbloglogo2014 On-line Enduring Material Teaches on Adrenal Nodules. Pheochromocytomas are fairly rare with about 1,000 cases in the U.S. every year but overall, adrenal tumors are common, and you can find one in about every 20 patients who undergo abdominal CT scans. Most of these adrenal tumors are benign and require no treatment but knowing which ones are consequential and which ones are inconsequential can be a challenge. On this CME webcast, to show you how to manage the incidentally identified adrenal tumor is surgical oncologist and Assistant Professor of Surgery at the Ohio State University, we have Dr. Drew Shirley.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: UNDERSTAND the imaging characteristics used to determine treatment strategies for adrenal nodules; and USE biochemical tests to aid in the diagnosis of functional adrenal nodules.

You’ll also learn about the following:

  • Causes of adrenal nodules
  • Which adrenal nodule need to be biopsied
  • Familial syndromes involving adrenal tumors
  • Incidental adrenal nodules found when staging lung cancer
  • Performing adrenal nodule needle biopsy and FNA
  • What to expect during and after adrenal surgery
  • Approach to adrenal hemorrhage
  • Radiographic imaging follow-up of adrenal nodules
  • Laboratory follow-up of adrenal nodules in patients with hypertension

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn About Accountable Care Organizations

OSUWexnerbloglogo2014 Learn about Accountable Care Organizations during our CME webcast. As of August 2017, there are 480 shared saving program ACOs covering 9 million Medicare beneficiaries. That is 1 out of every 5 people on Medicare today. On this CME webcast, we are going to introduce you to the Accountable Care Organization: why they exist, how they work, and whether you should participate in one. Joining our moderator in the studio are ACO experts from the Ohio State University. Dr. Randy Wexler is an Associate Professor and the Vice Chair of Clinical Affairs in the Department of Family Medicine. Also, we have Dr. Gail Grever who is an Assistant Professor of Internal Medicine in the Division of General Internal Medicine.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: better UNDERSTAND the cost reasons behind value based health care; UNDERSTAND the variations of value based reimbursement; DISCUSS elements necessary for success of an ACO; and better UNDERSTAND definition of Accountable Care Organizations.

You’ll also learn about the following:

  • HMOs versus ACOs
  • When should you expect to get an end of the year shared savings bonus
  • How baseline patient population characteristics affect the probability of an ACO’s success
  • Characteristics of a successful ACO structure
  • The role of the electronic medical record in an ACO
  • ACOs and commercial insurance companies
  • How are patients assigned to an ACO
  • Whether being in an ACO restricts a patient’s choice of doctors?

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

New Developments in Lung Cancer Treatment

OSUWexnerbloglogo2014 New Developments in Lung Cancer Treatment. Lung cancer now accounts for 14% of all cancers but it is the most common cause of cancer death, In fact, more people die each year from lung cancer than from colon cancer, breast cancer, and prostate cancer combined. The 5-year survival rate of lung cancer is only 18% but the good news is that we have a lot of new medications that are giving patients with lung cancer longer and better lives. On our CME webcast, to discuss new treatments in lung cancer, are two of Ohio State’s experts in the management of lung cancer. Joining our moderator, Dr. Jim Allen, we have Dr. Greg Otterson who is a Professor of Internal Medicine from the Division of Medical Oncology and Dr. Erin Bertino, an Assistant Professor of Internal Medicine, also from the Division of Medical Oncology.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: GAIN an understanding of the importance of genomic testing in the initial workup of patients with lung cancer. EXPLAIN the evolving role of immune mediated therapy in lung cancer; RECOGNIZE the clinical benefit for patients receiving targeted therapies; and DESCRIBE the patient characteristics commonly associated with actionable mutations in lung cancer.

You’ll also learn about the following:

  • The most fatal of all common cancers
  • Evolving chemotherapy treatment of lung cancer
  • Sub-classifying adenocarcinomas
  • Squamous cell lung cancer treatment
  • Large cell undifferentiated lung cancer

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.